Director · UNITED THERAPEUTICS Corp · Common Stock
Side
SELL
Value
$66K
Shares
130
Price
$505.79
Executed
Sep 14, 2026
Disclosed
Sep 15, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Sep 14 executedSep 15, 2026 disclosed
UTHR · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+4 / 15
1 prior trade recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Mesa Nilda filed this Form 4 reporting a open-market sale of UTHR on Sep 14, 2026. It became public on Sep 15, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Mesa Nildacik:0001756697
Issuer
UNITED THERAPEUTICS Corpcik:0001082554
Revision history · 0
No field has changed since this record was first ingested.
